• Skip to main content
  • Skip to primary sidebar
Pediatric Pulmonology: The Remaining Barriers to Normalcy in Cystic Fibrosis

The Remaining Barriers to Normalcy in Cystic Fibrosis

  • Issues
  • Resources
  • About
  • Contact
  • Search

2022 Quiz Answers

  • 1) Correct! The answer was d) 25-fold
  • 1) Incorrect. The answer was d) 25-fold
  • 2) Correct! The answer was d) All of the above
  • 2) Incorrect. The answer was d) All of the above
  • 3) Correct! The answer was b) Increased adverse drug interactions
  • 3) Incorrect. The answer was b) Increased adverse drug interactions
  • 4) Correct! The answer was c) Seek alignment with the overweight person using motivational interviewing techniques
  • 4) Incorrect. The answer was c) Seek alignment with the overweight person using motivational interviewing techniques
  • 5) Correct! The answer was b) Is often used as a substitute for airway clearance
  • 5) Incorrect. The answer was b) Is often used as a substitute for airway clearance
  • 6) Correct! The answer was c) Have limited access to highly effective modulator therapy in 2021
  • 6) Incorrect. The answer was c) Have limited access to highly effective modulator therapy in 2021
  • 7) Correct! The answer was a) During adolescence
  • 7) Incorrect. The answer was a) During adolescence
  • 8) Correct! The answer was d) > 40%
  • 8) Incorrect. The answer was d) > 40%
  • 9) Correct! The answer was b) Reduces nocturnal hypercapnia
  • 9) Incorrect. The answer was b) Reduces nocturnal hypercapnia
  • Thanks for completing the quiz!

  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

PP Cover - September 2024

Pediatric Pulmonology

Remaining Barriers to Normalcy in Cystic Fibrosis: Advances in Gastroenterology, Hepatology, and Nutrition

September 2024 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis VII

February 2022 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis VI

February 2021 · View Articles

List all issues »

Most Viewed Articles

  • Rapid therapeutic advances in CFTR modulator science

  • Reevaluating approaches to cystic fibrosis pulmonary exacerbations

  • Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors

  • Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

  • Inflammation in cystic fibrosis: An update

Quiz and Survey

Test your knowledge and help shape future editions of "The Remaining Barriers to Normalcy." Participate in our Quiz and Survey »

This website is made possible by an educational grant from Vertex Pharmaceuticals Incorporated.

Vertex

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2018-2025 John Wiley & Sons, Inc. All Rights Reserved.
The content on this site is intended for health professionals.
Wiley